Autophagy in Osteosarcoma.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 22 12 2020
Statut: ppublish

Résumé

Osteosarcoma (OS) remains a difficult disease to treat. The standard chemotherapy regimen has not improved survival for the past three decades. Resistance to chemotherapy remains a challenge and constitutes a major concern to clinical investigators. Autophagy has been recognized as a survival mechanism implicated in resistance to chemotherapy. We previously demonstrated chemotherapy to induce autophagy in OS. However, whether induction of autophagy will lead to survival or death has been the focus of many laboratories. Autophagy is a very context-dependent process, and no specific biomarker has been identified to define whether the process will lead to survival or death. In the present chapter, we present some of the mechanisms involved in the process of autophagy and summarize some of the most recent work related to autophagy in OS and the challenges encountered with the use of old and new autophagy inhibitors.

Identifiants

pubmed: 32767241
doi: 10.1007/978-3-030-43085-6_11
pmc: PMC9131842
mid: NIHMS1798205
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-175

Subventions

Organisme : NCI NIH HHS
ID : R01 CA042992
Pays : United States

Références

EBioMedicine. 2016 Dec;14:15-23
pubmed: 28029600
Autophagy. 2010 Nov;6(8):1209-11
pubmed: 20935509
Autophagy. 2014 Aug;10(8):1369-79
pubmed: 24991839
Oncogene. 2015 Oct 1;34(40):5105-13
pubmed: 25619832
Oncotarget. 2017 Aug 17;9(2):1602-1616
pubmed: 29416717
J Exp Clin Cancer Res. 2018 Aug 28;37(1):201
pubmed: 30153855
Tumour Biol. 2016 Jan;37(1):653-9
pubmed: 26242265
Genes Dev. 2011 Apr 1;25(7):717-29
pubmed: 21406549
Proc Natl Acad Sci U S A. 1982 Mar;79(6):1889-92
pubmed: 6952238
Radiat Res. 2011 May;175(5):547-60
pubmed: 21388295
Elife. 2017 Nov 17;6:
pubmed: 29148970
Autophagy. 2014 Aug;10(8):1359-68
pubmed: 24991840
Drug Discov Today Ther Strateg. 2009 Summer;6(2):47-55
pubmed: 20622997
Int J Oncol. 2014 May;44(5):1661-8
pubmed: 24585095
Cell Death Dis. 2018 May 23;9(6):611
pubmed: 29795113
Cancer Cell Int. 2019 Apr 03;19:82
pubmed: 30988663
Mol Biol Rep. 2014 May;41(5):3303-15
pubmed: 24500341
Int J Mol Sci. 2014 Feb 21;15(2):3145-53
pubmed: 24566140
J BUON. 2018 May-Jun;23(3):735-740
pubmed: 30003744
Transcription. 2018;9(2):131-136
pubmed: 28980873
Biochim Biophys Acta. 2009 Jan;1792(1):3-13
pubmed: 19022377
Nature. 2017 Jan 19;541(7637):417-420
pubmed: 28077876
Autophagy. 2012 Feb 1;8(2):275-7
pubmed: 22301993
Mol Cell. 2017 Mar 2;65(5):781-785
pubmed: 28257699
Cells. 2012 Aug 13;1(3):520-34
pubmed: 24710488
BMC Cancer. 2013 Oct 26;13:500
pubmed: 24160177
Oncotarget. 2015 Nov 3;6(34):36354-69
pubmed: 26497553
Mol Cancer Ther. 2018 Jun;17(6):1315-1323
pubmed: 29592877
Cancer Res. 2012 Jan 1;72(1):230-8
pubmed: 22102692
Medicine (Baltimore). 2018 Nov;97(46):e12912
pubmed: 30431566
Ann Surg Oncol. 2011 Dec;18 Suppl 3:S239
pubmed: 21603870
Autophagy. 2019 Feb;15(2):295-311
pubmed: 30176161
Cell Mol Life Sci. 2016 Mar;73(5):985-1001
pubmed: 26658914
Protein Cell. 2012 Jan;3(1):17-27
pubmed: 22314807
Autophagy. 2015;11(6):867-80
pubmed: 25836756
Nat Rev Cancer. 2017 Sep;17(9):528-542
pubmed: 28751651
Curr Opin Pharmacol. 2011 Aug;11(4):294-300
pubmed: 21498118
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8
pubmed: 22566612
Gastroenterology. 2017 May;152(6):1492-1506.e24
pubmed: 28126348
Mol Cancer Ther. 2011 Sep;10(9):1533-41
pubmed: 21878654
J Exp Clin Cancer Res. 2018 Aug 9;37(1):188
pubmed: 30092789
Front Immunol. 2018 Jul 31;9:1512
pubmed: 30108582
Arch Med Sci. 2019 Jan;15(1):204-213
pubmed: 30697272
Nat Rev Mol Cell Biol. 2014 Jan;15(1):65-74
pubmed: 24326622
J Cell Sci. 2012 May 15;125(Pt 10):2349-58
pubmed: 22641689
Science. 2011 Jun 17;332(6036):1429-33
pubmed: 21617040
J Exp Clin Cancer Res. 2018 Jul 3;37(1):135
pubmed: 29970115
Can J Cardiol. 2017 Jul;33(7):850-859
pubmed: 28389131
Postgrad Med J. 2009 Mar;85(1001):134-40
pubmed: 19351640
Med Sci (Paris). 2017 Mar;33(3):319-327
pubmed: 28367820
Oncol Lett. 2013 Nov;6(5):1465-1469
pubmed: 24179542
Tumour Biol. 2015 Apr;36(4):2531-9
pubmed: 25427639
Oncol Rep. 2015 Apr;33(4):1699-706
pubmed: 25647019
Aging Dis. 2017 Oct 1;8(5):628-642
pubmed: 28966806
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5867-5873
pubmed: 30280766
Oncotarget. 2018 Aug 31;9(68):32997-33010
pubmed: 30250645
Autophagy. 2012 Sep;8(9):1383-4
pubmed: 22878685

Auteurs

Grace Nehme (G)

Department of Pediatric Research, MD Anderson Cancer Center, Houston, TX, USA.

Nancy Gordon (N)

Department of Pediatric Research, MD Anderson Cancer Center, Houston, TX, USA. ngordon@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH